Studies are limited, but health experts say imbibing on a GLP-1 drug can carry some theoretical risks. Here are 7 things to ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

AI, ADCs, gene therapies disrupt South Koreas pharmaceutical market by 2025 Emerging technologies signal transformative ...

Imagine if you could eat your fill on Christmas day then dial down your appetite for January. Good news: such a prospect may ...

But the new research has concluded that a low-dose minoxidil pill taken during or after breast cancer treatment can regrow hair in female patients without any serious side effects. Related Task ...

Mercks Keytruda tops global pharmaceutical sales as Humira drops out of top 10 Mercks cancer drug dominates global sales ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

The FDA has approved Zepbound, a weight-loss medication, as the first drug treatment for moderate to severe obstructive sleep ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer ... reduced quality of life and other side effects that may be avoidable," Hwang ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

In a major development, the first drug treatment option for certain patients with obstructive sleep apnea (OSA) is now ...